日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Model-Based Meta-Analysis of Overall Survival in Vulnerable Platinum-Ineligible NSCLC Populations

基于模型的脆弱性非小细胞肺癌患者(不适合铂类化疗)总生存期荟萃分析

Chen, Joseph; Wada, Russ; Zhang, Nancy; Graupner, Vilma; Morris, Stefanie; Hu, Youyou; Zhang, Wei; Kassir, Nastya; Wu, Benjamin; Chan, Phyllis

Oncology Dose Optimization: Tailored Approaches to Different Molecular Classes

肿瘤剂量优化:针对不同分子类型的个体化方法

Zhu, Jiawen; Schroeder, Amy; Frank, Sabine; Boetsch, Christophe; Jamois, Candice; Kassir, Nastya; Korfi, Koorosh; Punnoose, Elizabeth; Vaze, Anjali; Trask, Peter; Gosai, Pritti; Fridlyand, Jane; Li, Chunze

Mechanistic Physiologically Based Pharmacokinetic Modeling of Dry Powder and Nebulized Formulations of Orally Inhaled TMEM16A Potentiator GDC-6988

基于机制生理的口服吸入TMEM16A增效剂GDC-6988干粉和雾化制剂的药代动力学模型

Zhu, Rui; Sorrell, Ian; Ma, Fang; Ning, Miaoran; Son, Yoen-Ju; She, Gaohong; De Bruyn, Tom; Galanter, Joshua; Kassir, Nastya; Owen, Ryan; Jamei, Masoud; Gardner, Iain; Chen, Yuan

Population Pharmacokinetics and Exposure-Response Relationships of Etrolizumab in Patients with Moderately-to-Severely Active Crohn's Disease

中重度活动性克罗恩病患者中依曲利珠单抗的群体药代动力学和暴露-反应关系

Moein, Anita; Ribbing, Jakob; Ibrahim, Moustafa M A; Zhang, Wenhui; Kassir, Nastya

Predicting overall survival from tumor dynamics metrics using parametric statistical and machine learning models: application to patients with RET-altered solid tumors

利用参数统计和机器学习模型,根据肿瘤动力学指标预测总生存期:应用于RET基因改变的实体瘤患者

Velasquez, Erick; Kassir, Nastya; Cheeti, Sravanthi; Kuruvilla, Denison; Sane, Rucha; Dang, Steve; Miles, Dale; Lu, James

Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib

通过PBPK模型了解CYP3A4和P-gp介导的药物相互作用——以普拉替尼为例

Bowman, Christine; Dolton, Michael; Ma, Fang; Cheeti, Sravanthi; Kuruvilla, Denison; Sane, Rucha; Kassir, Nastya; Chen, Yuan

Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus

抗利妥昔单抗抗体具有中和能力,与循环药物浓度降低和狼疮复发提前相关。

Wincup, Chris; Dunn, Nicky; Ruetsch-Chelli, Caroline; Manouchehrinia, Ali; Kharlamova, Nastya; Naja, Meena; Seitz-Polski, Barbara; Isenberg, David A; Fogdell-Hahn, Anna; Ciurtin, Coziana; Jury, Elizabeth C

External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib data

利用阿来替尼数据,对基于阿特珠单抗研究的非小细胞肺癌肿瘤生长抑制-总生存期模型进行外部验证

Kassir, Nastya; Chan, Phyllis; Dang, Steve; Bruno, René

Antibodies to a Citrullinated Porphyromonas gingivalis Epitope Are Increased in Early Rheumatoid Arthritis, and Can Be Produced by Gingival Tissue B Cells: Implications for a Bacterial Origin in RA Etiology

早期类风湿性关节炎患者体内针对瓜氨酸化牙龈卟啉单胞菌表位的抗体水平升高,且该抗体可由牙龈组织B细胞产生:提示类风湿性关节炎的病因可能与细菌有关。

Sherina, Natalia; de Vries, Charlotte; Kharlamova, Nastya; Sippl, Natalie; Jiang, Xia; Brynedal, Boel; Kindstedt, Elin; Hansson, Monika; Mathsson-Alm, Linda; Israelsson, Lena; Stålesen, Ragnhild; Saevarsdottir, Saedis; Holmdahl, Rikard; Hensvold, Aase; Johannsen, Gunnar; Eriksson, Kaja; Sallusto, Federica; Catrina, Anca I; Rönnelid, Johan; Grönwall, Caroline; Yucel-Lindberg, Tülay; Alfredsson, Lars; Klareskog, Lars; Piccoli, Luca; Malmström, Vivianne; Amara, Khaled; Lundberg, Karin

Exposure-response relationships of etrolizumab in patients with moderately-to-severely active ulcerative colitis

在患有中重度活动性溃疡性结肠炎的患者中,etrolizumab 的暴露-反应关系

Kassir, Nastya; Zhu, Rui; Moein, Anita; Langenhorst, Jurgen; Ribbing, Jakob; Zhang, Rong; Tang, Meina T; Oh, Young S; Zhang, Wenhui